首页> 外文期刊>American Journal of Physiology >Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system.
【24h】

Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system.

机译:新型肝糖6磷酸酶抑制剂的药效学特征。

获取原文
获取原文并翻译 | 示例
           

摘要

The glucose-6-phosphatase (G-6-Pase) system catalyzes the terminal enzymatic step of gluconeogenesis and glycogenolysis. Inhibition of the G-6-Pase system in the liver is expected to result in a reduction of hepatic glucose production irrespective of the relative contribution of gluconeogenesis or glycogenolysis to hepatic glucose output. In isolated perfused rat liver, S-3483, a derivative of chlorogenic acid, produced concentration-dependent inhibition of gluconeogenesis and glycogenolysis in a similar concentration range. In fed rats, glucagon-induced glycogenolysis resulted in hyperglycemia for nearly 2 h. Intravenous infusion of 50 mg kg-1 h-1 S-3483 prevented the hyperglycemic peak and subsequently caused a further lowering of blood glucose. In 24-h starved rats, in which normoglycemia is maintained predominantly by gluconeogenesis, intravenous infusion of S-3483 resulted in a constant reduction of blood glucose levels. Intrahepatic concentrations of glucose-6-phosphate (G-6-P) and glycogen were significantly increased at the end of both in vivo studies. In contrast, lowering of blood glucose in starved rats by 3-mercaptopicolinic acid was accompanied by a reduction of G-6-P and glycogen. Our results demonstrate for the first time in vivo a pharmacologically induced suppression of hepatic G-6-P activity with subsequent changes in blood glucose levels.
机译:葡萄糖-6-磷酸酶(G-6-Pase)系统催化糖异生和糖原分解的最终酶促步骤。不管肝糖异生或糖原分解对肝葡萄糖输出的相对贡献如何,预期肝脏中G-6-Pase系统的抑制都会导致肝葡萄糖生成的减少。在分离的灌注大鼠肝脏中,绿原酸的衍生物S-3483在相似的浓度范围内产生了对糖异生和糖原分解的浓度依赖性抑制。在饲喂的大鼠中,胰高血糖素诱导的糖原分解作用导致近2小时的高血糖。静脉输注50 mg kg-1 h-1 S-3483可以防止血糖过高,进而导致血糖​​进一步降低。在主要通过糖异生来维持血糖正常的24小时饥饿的大鼠中,静脉输注S-3483导致血糖水平不断降低。在两项体内研究结束时,肝内葡萄糖6-磷酸(G-6-P)和糖原的浓度均显着增加。相反,饥饿的大鼠中3-巯基亚油酸的血糖降低伴随着G-6-P和糖原的降低。我们的结果首次证明了体内药理学诱导的对肝G-6-P活性的抑制以及随后血糖水平的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号